Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Open-market buys, last 90 days
$5,999,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$5,999,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BROADWOOD PARTNERS, L.P. +$6.0M 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-11-17 SMITH PATRICK W 10% owner Other acquisition +1,142,857 $1.75 $2.0M 4,401,342
2025-02-07 SMITH PATRICK W 10% owner Purchase +1,077,600 $2.05 $2.2M 2,872,671
2025-02-07 SMITH PATRICK W 10% owner Other acquisition +385,814 $2.05 $791K 3,258,485
2025-02-04 SMITH PATRICK W 10% owner Purchase +25 $2.02 $51 1,795,071
2025-01-31 SMITH PATRICK W 10% owner Purchase +890 $2.01 $2K 1,795,046
2025-01-30 SMITH PATRICK W 10% owner Purchase +318 $2.01 $639 1,794,156
2025-01-29 SMITH PATRICK W 10% owner Purchase +3,880 $2.01 $8K 1,793,838
2025-01-14 SMITH PATRICK W 10% owner Purchase +100 $2.08 $208 1,779,672
2025-01-14 SMITH PATRICK W 10% owner Purchase +10,286 $2.15 $22K 1,789,958
2025-01-13 SMITH PATRICK W 10% owner Purchase +5,669 $2.08 $12K 1,779,572
2024-12-26 SMITH PATRICK W 10% owner Purchase +90,219 $2.13 $192K 1,773,903

Page 1 of 1 · 11 trades